ABT

$115.93

▼-1.02%

wb_incandescent Backtest

Stock

Abbott Laboratories Common Stock

Official Company Name: Abbott Laboratories

Stock Symbol: ABT

Stock Market: New York Stock Exchange - NYSE

Currency: United States dollar - USD

business Abbott Company Profile

ABT Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+12.87%

file_download

Daily closing prices, with moving averages and volumes - United States dollar (USD)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Abbott Laboratories is a multinational health care and medical devices company. Founded in 1888, Abbot manufactures medical devices including cardiovascular and neuromodulation devices, diagnostics products, branded generic medicines, and nutritional products for children and adults including Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.

business Abbott Company Profile

ABT Stock Data

Open $116.69
High $116.77
Low $115.53
Close $115.93
Volume 5,624,400
Previous Close $117.13
1-Day Change -1.20
1-Year Change 13.22
Average Daily Volume 5,668,004
52-Week High $120.96
52-Week Low $100.07

ABT Stock References

warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.